Sp483

THE ENIGMA OF LGD: IS IT THE REAL DEAL?

Date
May 7, 2023
Explore related products in the following collection:

Society: ASGE


Tracks

Related Products

Thumbnail for ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT'S ESOPHAGUS RELATED NEOPLASIA: PRELIMINARY RESULTS FROM A PROSPECTIVE EUROPEAN MULTICENTER STUDY
ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT'S ESOPHAGUS RELATED NEOPLASIA: PRELIMINARY RESULTS FROM A PROSPECTIVE EUROPEAN MULTICENTER STUDY
Focal cryoballoon ablation (FCBA) is a relatively new ablation modality for the treatment of Barrett’s esophagus (BE) related neoplasia. This prospective, European multicenter study (Euro-Coldplay, NTR NL7253) aimed to evaluate the efficacy and safety of FCBA for the treatment of limited BE…
Thumbnail for VIDEO-BASED COMPUTER AIDED DETECTION SYSTEM DETECTS BARRETT’S NEOPLASIA WITH HIGH ACCURACY DURING LIVE ENDOSCOPIC PROCEDURES: A MULTI-CENTER PILOT AND FEASIBILITY STUDY
VIDEO-BASED COMPUTER AIDED DETECTION SYSTEM DETECTS BARRETT’S NEOPLASIA WITH HIGH ACCURACY DURING LIVE ENDOSCOPIC PROCEDURES: A MULTI-CENTER PILOT AND FEASIBILITY STUDY
BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
Thumbnail for ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: INTERIM RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: INTERIM RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…
Thumbnail for FEASIBILITY AND SAFETY OF TAILORED LYMPHADENECTOMY USING SENTINEL NODE NAVIGATED SURGERY WITH A HYBRID TRACER OF TECHNETIUM-99M AND INDOCYANINE GREEN IN HIGH-RISK T1 ESOPHAGEAL ADENOCARCINOMA PATIENTS
FEASIBILITY AND SAFETY OF TAILORED LYMPHADENECTOMY USING SENTINEL NODE NAVIGATED SURGERY WITH A HYBRID TRACER OF TECHNETIUM-99M AND INDOCYANINE GREEN IN HIGH-RISK T1 ESOPHAGEAL ADENOCARCINOMA PATIENTS
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM